IFNG and neoplasm: Hence, it is not surprising that previous studies suggest that epigenetic modifications may be able to convert a tumor cell that is operationally invisible to the immune system into an effective antigen presenting cell (APC) capable of activating IFN-γ secreting T cells via the MHC class I-presentation pathway.